Diabetes and HIV Diabetes is the fastest growing chronic health condition in Australia. Jason Appleby and Megan Gayford look at diabetes among people living with HIV.
13 March 2008
Vol. 6 No. 1
AIDS 2006: New Treatments The Toronto XVI International AIDS Conference in Canada 2006 presented some new treatment developments that look promising for people with HIV/AIDS in Australia. This report provides a summary of these developments and is based on a presentation by the AIDS Council of NSW (ACON).
The pregnancy test Kirsty Machon looks at proposed changes to HIV testing among pregnant women.
Microbicides 2006 The future of microbicides development in the fight against HIV is discussed by Theo Smart following an international conference on the topic in South Africa last year.
Vol. 5 No. 2
October - December 2005
All aboard the STEAL expressThe STEAL study which will compare two once daily HIV treatment regimens is underway. PETER WATTS reports.
Fleshing it out KIRSTY MACHON reports on the FLASH study which will see 100 people in four states receiving treatment with Sculptra, a plastic surgery product which is thought to ‘fill out’ the cheeks and promote collagen growth.
The kindest cut?To cut or not to cut may come down to more than just aesthetics, reports DR DARREN RUSSELL.
Pre exposure prophylaxis With no forseeable HIV vaccine on the horizon, are HIV negative gay men taking matters into their own hands, asks TONY MAYNARD.
Shadowing the facts FREDERIC BOURDIER argues that the Cambodian decision to rule out a proposed trial of the HIV drug Tenofovir as a prophylaxis among sex workers was in fact justified.
New HIV Vaccine trial in Sydney BRIDGET HAIRE outlines a new vaccine trial that aims to recruit Sydney gay men at high risk of HIV infection.
Human Rights
Vol. 4 No. 2
December 2004 - February 2005
Fighting fat KIRSTY MACHON reports on the latest research in lipodystrophy.
Vol. 3 No. 4
June - August 2004
HIV Treatments - The State of Play TONY MAYNARD gives an overview of nearly two decades of HIV medication and looks ahead to the new classes of drugs becoming available.
Access in Asia Reports on the AFAO Community Sector Workshop on HIV Treatment Access: "Building Policy & Advocacy Capacity in Southeast Asia", Bangkok, 16-19 March 2004.
Vol. 3 No. 3
March - May 2004
Reality CheckBRIDGET HAIRE reports on the results from the Australian trial of a therapeutic HIV vaccine.
Vol. 3. No. 2
December 2003 - February 2004
With 18 microbicide candidates earmarked for clinical trials, VICKI BURKITT takes a look at what’s happening in microbicides.
Week on/week off treatment break cycles have been effectively scuttled as a potential treatment strategy, KIRSTY MACHON reports.
A panel of experts, including Marty Markowitz and Alan Landay shared their ideas about cutting-edge HIV treatment issues at the recent ASHM conference in Cairns.
Treatment side effects can be a shitty matter, reportsROSS DUFFIN; and
ANN McDONALD and JOHN KALDOR look at the methods used to monitor the pattern of HIV transmission in Australia - from surveillance for cases of newly diagnosed HIV infection and AIDS to sentinel surveillance among population sub-groups at higher and lower risk of HIV infection.
Tony Maynard outlines ways to reduce the risk of cardiovascular disease.
Talata Reeves explores in-depth the details of a study which reported the first case of female to female transmission in scientific literature and comments on its significance in light of current research in the United States concerning HIV risk and prevention for women who have sex with women.
Robin Gorna and Peter Canavan report on treatments access in developing countries. Download the stories in PDF format (43 KB).
Vol 2. No. 1
September/October 2002
Selected articlesfrom the special issue on the 14th International AIDS Conference at Barcelona. (PDF 184 KB)
An overview of the epidemiology stream; research into HIV-specific immune responses which will slow HIV disease progression; news on vaccines; and preventative treatment for HIV negative people in high-risk groups.
Vol 1. No. 4
June - July 2002
Antiretroviral treatments have changed the landscape of HIV. However, the decision on when to start taking treatments is fought with questions.
Raising awareness of primary HIV infection for those at risk and their doctors is discussed by Tony Maynard.
The state of play: HIV treatment (PDF 22KB).
As we move into the second quarter of 2002, the state of play in HIV treatments is changing. Dr MARK KELLY reflects upon the contemporary experience of HIV disease and the current issues emerging in HIV treatment.
Also in this issue: (PDF 28 KB)
Therapeutic drug monitoring - is it going to become the next common test in HIV management, or has its usefulness been over-hyped? and HIV entry inhibitors: the next class of antiretroviral drugs.
Vol 1. No. 2.
February - March 2002 (PDF 29KB)
Brain involvement in HIV disease and the recent research on treatment interruptions.
Vol 1. No 1.
December January 2001 - 02 (PDF 34KB)
Highlights from the Australasian Society of HIV Medicine's Conference and the draft Australian Antiretroviral Guidelines.
